However, unlike the results in CML, miR-34a had only a minor effect on decreasing ATG4B protein expression (Figure 6A), suggesting that ATG4B is not a direct target of miR-34a in PC3 cells. This evidence concerns the gene ATG4B and chronic myelogenous leukemia, BCR-ABL1 positive.